Patents by Inventor Guoguang WU

Guoguang WU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220170103
    Abstract: The disclosure provides a genotyping kit for detection of six CD36 mutant genes that encode GPIV deficiency. The kit includes six primers configured to amplify a sequence of CD36 wile-type gene, six primers configured to amplify a sequence of CD36 mutant genes, and six universal primers. The mutations of CD36 gene include the following mutation sites: C275T (Thr92Met), 730G>A (Asp244Asn), Exon-10+2 T>G (Change in splicing site), 1123C>T (Pro375Ser), 1229T>C (Ile410Thr), and 1332 ints TGAT (frameshift at AA 445).
    Type: Application
    Filed: February 16, 2022
    Publication date: June 2, 2022
    Inventors: Lilan LI, Guoguang WU
  • Patent number: 10711046
    Abstract: A method for establishing eukaryotic expression cell line of CD36 mutant gene that encodes CD36 deficiency, the method including: (1) extracting total RNA from a whole blood sample derived from a CD36-deficient individual, and amplifying a coding sequence (CDS) in CD36 mRNA, to obtain a cDNA sequence fragment of the mutant CD36 gene; (2) splicing and amplifying the mutant CD36 gene and the EGFP fluorescent gene by SOE-PCR (Gene Splicing By Overlap Extension PCR) using four forward and reverse primers, to obtain a mutant gene fragment of MT-CD36-EGFP; (3) constructing and amplifying a MT-CD36-EGFP-pLV4/StripII-HIS10 eukaryotic expression vector including the mutant CD36 gene and the EGFP fluorescent gene; (4) transfecting the MT-CD36-EGFP-pLV4/StripII-HIS10 eukaryotic expression vector into the CHO-K1 cell line by using virus-mediated transfection of eukaryotic cells.
    Type: Grant
    Filed: November 12, 2018
    Date of Patent: July 14, 2020
    Assignee: NAN-NING INSTITUTE OF TRANSFUSION MEDICINE
    Inventors: Guoguang Wu, Lilan Li, Lihong Jiang, Haiyan Li, Jierun Chen
  • Publication number: 20190062387
    Abstract: A method for establishing eukaryotic expression cell line of CD36 mutant gene that encodes CD36 deficiency, the method including: (1) extracting total RNA from a whole blood sample derived from a CD36-deficient individual, and amplifying a coding sequence (CDS) in CD36 mRNA, to obtain a cDNA sequence fragment of the mutant CD36 gene; (2) splicing and amplifying the mutant CD36 gene and the EGFP fluorescent gene by SOE-PCR (Gene Splicing By Overlap Extension PCR) using four forward and reverse primers, to obtain a mutant gene fragment of MT-CD36-EGFP; (3) constructing and amplifying a MT-CD36-EGFP-pLV4/StripII-HIS10 eukaryotic expression vector including the mutant CD36 gene and the EGFP fluorescent gene; (4) transfecting the MT-CD36-EGFP-pLV4/StripII-HIS10 eukaryotic expression vector into the CHO-K1 cell line by using virus-mediated transfection of eukaryotic cells.
    Type: Application
    Filed: November 12, 2018
    Publication date: February 28, 2019
    Inventors: Guoguang WU, Lilan LI, Lihong JIANG, Haiyan LI, Jierun CHEN